Cancer Family
Lymphocytic Neoplasm
CI-CAN-00000223Explore in graph →
HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items
- NCIt
- C7065
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000223Explore in graph →
Clinical trials
12,949 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005580 | Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma | completed | Phase 1 | 54 | Virginia Commonwealth UniversityOTHER | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00304590 | Study of XL999 in Patients With Multiple Myeloma | terminated | Phase 2 | 4 | Symphony Evolution, Inc.INDUSTRY | 1 | Feb 22, 2010 | clinicaltrials |
| NCT01070862 |
| completed |
| Phase 3 |
| — |
| University Hospital, CaenOTHER |
| 1 |
| Feb 18, 2010 |
| clinicaltrials |
| NCT00003079 | Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma | completed | Phase 1 | 30 | Virginia Commonwealth UniversityOTHER | 1 | Feb 17, 2010 | clinicaltrials |
| NCT01066429 | DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma | unknown | Phase 2 | 30 | Hospital Universitario Principe de AsturiasOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00544570 | High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma | completed | N/A | 30 | City of Hope Medical CenterOTHER | 0 | Feb 9, 2010 | clinicaltrials |
| NCT00222612 | Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 | unknown | Phase 4 | 2,100 | University of OxfordOTHER | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00124813 | Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma | unknown | Phase 2 | 80 | University Hospital, BonnOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00251394 | Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 29, 2010 | clinicaltrials |
| NCT00740467 | Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders | unknown | Phase 2 | 50 | Institut Paoli-CalmettesOTHER | 1 | Jan 28, 2010 | clinicaltrials |
| NCT00147953 | Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 2 | 30 | University of CologneOTHER | 1 | Jan 27, 2010 | clinicaltrials |
| NCT00004058 | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder | terminated | Phase 1 | — | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00301288 | A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL). | completed | — | 152 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00301301 | A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) | completed | — | 39 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00301314 | A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL). | completed | — | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00459069 | The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma | completed | Phase 1 | 18 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00571168 | Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy(EmNa) | unknown | Phase 3 | 362 | Heidelberg UniversityOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00276003 | INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. | completed | Phase 2 | 22 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00526305 | LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive | completed | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT00182650 | Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma | completed | Phase 1 | 5 | City of Hope Medical CenterOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00153530 | Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL) | completed | Phase 4 | 604 | Charite University, Berlin, GermanyOTHER | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00229203 | A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma | completed | Phase 2 | 51 | PharmaMarINDUSTRY | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00292760 | A Single-arm Phase II Study of Alemtuzumab in Combination With High-dose Methylprednisolone in CLL Patients With p53 Deletion | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 0 | Dec 16, 2009 | clinicaltrials |
| NCT00161239 | LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma | terminated | N/A | 64 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Dec 11, 2009 | clinicaltrials |
| NCT00466258 | LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)(LINFOTARGAM) | completed | Phase 4 | 50 | PETHEMA FoundationOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT01018758 | Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy(NHLPal) | completed | Phase 2 | 86 | Gruppo Italiano Studio LinfomiOTHER | 1 | Nov 25, 2009 | clinicaltrials |
| NCT00243763 | TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma | terminated | Phase 1 | 64 | NovartisINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00195533 | Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients | completed | — | 801 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Nov 16, 2009 | clinicaltrials |
| NCT00021749 | Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia | completed | Phase 1 / Phase 2 | 40 | Genta IncorporatedINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00608452 | Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers | completed | — | 121 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 13, 2009 | clinicaltrials |
| NCT01008735 | Gonadal Toxicity in Women With Hodgkin Lymphoma(FertHD) | unknown | — | 150 | Gruppo Italiano Studio LinfomiOTHER | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00136474 | Amifostine for Head and Neck Irradiation in Lymphoma | completed | Phase 2 | 75 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00165269 | Mantle Irradiation for Hodgkin's Disease | completed | Phase 2 | 100 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00418535 | Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma | completed | Phase 2 | — | Samsung Medical CenterOTHER | 1 | Oct 21, 2009 | clinicaltrials |
| NCT00090038 | Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 4 | 168 | BiogenINDUSTRY | 11 | Oct 20, 2009 | clinicaltrials |
| NCT00374699 | Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas | completed | Phase 1 / Phase 2 | 55 | Samsung Medical CenterOTHER | 1 | Oct 14, 2009 | clinicaltrials |
| NCT00520637 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) | completed | Phase 1 | 34 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 9, 2009 | clinicaltrials |
| NCT00006246 | Busulfan in Treating Children and Adolescents With Refractory CNS Cancer | completed | Phase 1 | 28 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00989352 | Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma(PRIMAIN) | unknown | Phase 2 | 56 | University Hospital FreiburgOTHER | 1 | Oct 5, 2009 | clinicaltrials |
| NCT00631579 | Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma | completed | Phase 2 | 50 | SanofiINDUSTRY | 1 | Oct 2, 2009 | clinicaltrials |
| NCT00988312 | Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma | completed | Phase 1 | 9 | University Hospital Carl Gustav CarusOTHER | 1 | Oct 2, 2009 | clinicaltrials |
| NCT00141648 | Chemotherapy and Radiotherapy for Osteolymphoma | completed | N/A | 70 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Oct 1, 2009 | clinicaltrials |
| NCT00041730 | Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma | unknown | Phase 2 | 90 | FavrilleINDUSTRY | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00192673 | Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses | unknown | Phase 4 | 85 | Nordic Society for Pediatric Hematology and OncologyOTHER | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00471367 | Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877 | terminated | Phase 1 | 44 | AstraZenecaINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00051116 | A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma | completed | Phase 2 | 100 | Celgene CorporationINDUSTRY | 1 | Sep 23, 2009 | clinicaltrials |
| NCT00425347 | Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma | completed | Phase 1 | 35 | Facet BiotechINDUSTRY | 1 | Sep 23, 2009 | clinicaltrials |
| NCT00980304 | R Retreatment in 1st Relapsed DLBCL | unknown | Phase 2 | — | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Sep 21, 2009 | clinicaltrials |
| NCT00354822 | Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.(Z0105) | terminated | Phase 2 | 25 | A.O. Ospedale Papa Giovanni XXIIIOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00391157 | VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma | completed | Phase 2 | 40 | PETHEMA FoundationOTHER | 1 | Sep 18, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Feb 24, 2010source: clinicaltrials